Abstract
Tacrolimus has been effective both in primary and rescue therapy following steroid and OKT3-resistant acute rejection in liver and kidney transplantation. Due to the effects of tacrolimus on glucose metabolism, there has been concern about its use in simultaneous pancreas/kidney transplantation. We report on the results of six patients (three female, three male, age 35.2 ± 7.3 years) converted from cyclosporin A to tacrolimus following simultaneous pancreas/kidney transplantation in steroid-resistant acute rejection. Tacrolimus was induced 2.8 ± 1.7 months (range 1–4.8 months) after transplantation; follow-up was 3–18 months. Following conversion, creatinine levels declined in all patients [3.5 ± 1.2 mg/dl before conversion, 3.0 ± 1.9 mg/dl (n = 6) at three months, 1.4 ± 0.1 mg/dl at 1 year (n = 3)]. Before conversion, fasting blood glucose levels averaged 154 ± 33 mg/dl, with three patients receiving insulin. Three months later no patient required insulin, the mean glucose level being 107 ± 23 mg/dl (n = 6); at 1 year it was 92 ± 9 mg/dl (n = 3). One patient lost his pancreatic graft after 4 months due to a mycotic aneurysm. We conclude that conversion to tacrolimus is a safe and effective treatment in cases of steroid-resistant rejections following pancreas/kidney transplantation.
Similar content being viewed by others
References
Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO (1996) Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Transplant Proc 28: 995–997
Burke GW, Alejandro R, Cianco G, Nery J, Roth D, Shapiro R, Scantlebury V, Skyler JS, Ricordi C, Tzakis A, Miller J (1995) The use of FK 506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. Transplant Proc 27: 3123–3124
European FK506 multicenter liver study group (1994) Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 344: 423–425
Gruessner RWG, Burke GW, Stratta R, Solllinger H, Benedetti E, Marsh C, Stock P, Boudrex P, Martin M, Drangstveit MB, Sutherland DER, Gruessner A (1996) A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 61: 261–273
Jordan ML, Shapiro R, Scantlebury VP, Fung J, Tzakis A, McCauley J, Jain A, Demetris J, Randhawa P (1991) FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 23: 3078–3081
Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Darras FS, Carrieri G, McCauley J, Demetris AJ, Randhawa P, Jensen C (1993) FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. Transplant Proc 25: 638–640
Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Rhandhawa P, Carrieri G, McCauley J, Demetris AJ, Tzakis A, Fung JJ, Simmons RL, Hakala TR, Starzl TE (1994) FK506 “rescue” for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 57: 860–864
Klintmalm GBG, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, U. S. Multicenter FK 506 study group (1993) Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. Transplant Proc 25: 679–688
Krentz AJ, Dmitrewski J, Mayer D, McMaster P, Buckels J, Dousset B, Cramb R, Smith JM, Nattrass M (1994) Postoperative glucose metabolism in liver transplant recipients: a two-year prospective randomized study of cyclosporine versus FK506. Transplantation 57: 1666–1669
Lewis WD, Jenkins RL, Burke PA, Winn KM, Shaffer D, Lopez R, Monaco AP (1991) FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. Transplant Proc 23: 2989–2991
Oh CS, Stratta RJ, Fox BC, Sollinger HW, Belzer FO, Maki DG (1988) Increased infections associated with the use of OKT3 for treatment of steroidresistant rejection in renal transplantation. Transplantation 45: 68–73
Rilo M, Zeng Y, Alejandro R (1991) Effect of FK506 on function of human islets of Langerhans. Transplant Proc 23:3164–3165
Rosen CB, Frohnert PP, Velosa JA, Engen DE, Sterioff S (1991) Morbidity of pancreas transplantation during cadaveric renal transplantation. Transplantation 51:123–127
Scantlebury VP, Shapiro R, Fung J, Tzakis A, McCauley J, Jordan M, Jensen C, Hakala T, Simmons R, Starzl TE (1991) New onset diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 23: 3169–3170
Shaffer D, Madras PN, Sahyoun AI, Williams ME, Kaldany A, D'Elia JA, Monaco AP (1992) Combined kidney and pancreas transplantation: a 3 year experience. Arch Surg 127: 574–578
Shaffer D, Simpson MA, Conway P, Madras PN, Monaco AP (1995) Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). Transplantation 59:1063–1066
Stratta RJ, Taylor P, Castaldo P, Sindhi R, Sudan D, Weide LG, Frisbie K, Cushing KA, Jerius J, Radio SJ (1996) FK 506 induction and rescue therapy in pancreas transplant recipients. Transplant Proc 28: 991–992
Tabasco-Minguillan J, Mieles L, Caroll R, Gavaler J, Van Theil DH, Starzl TE (1993) Long-term insulin requirement after liver transplantation with FK 506 in American veterans. Transplant Proc 25:677–678
Teraoka S, Babazono T, Koike T, Abe M, Kimikawa M, Shinkai M, Haruguchi H, Hirotani S, Kitajima M, Akamatsu M, Ozaki M, Fujita S, Nakajima I, Kawai T, Fuchinoue S, Ota K, Tomonaga O, Yano K, Tasaka Y, Omori Y (1995) Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 27:1335–1339
Tze WJ, Tai J, Murase N, Tzakis A, Starzl TE (1991) Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc 23: 3158–3160
U. S. Multicenter FK 506 liver study group (1994) A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110–1115
Wadström J, Brekke B, Wrammer L, Ekberg H, Tyden G (1995) Triple versus quadruple induction immunosuppression in pancreas transplantation. Transplant Proc 27: 1317–1318
Author information
Authors and Affiliations
About this article
Cite this article
Becker, G., Witzke, O., Friedrich, J. et al. Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation. Transplant Int 10, 51–54 (1996). https://doi.org/10.1007/BF02044342
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02044342